CS Diagnostics Corp. (OTCPK: CSDX)
Health Care · Health Care Providers & Services · US
$0.01
-85.00% today · -89.5% 1Y
CS Diagnostics Corp. (OTCPK: CSDX) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $2.62M and employs 1 people.
Over the last twelve months the share price has lost 89.5%, trading between 0.01 and 0.40.
Tweenvest scores CS Diagnostics Corp. across four factors: quality 57/100, value 61/100. Its strongest factor is value.
CSDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.62M
- Revenue (TTM)
- $204.00K
- P/E
- 36.97
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- -21.35
- 52-week high
- $0.40
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 249.99M
- Employees
- 1
- Next earnings
- —
About CS Diagnostics Corp.
Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996. The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications. The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.
- ISIN
- US33852L2025
- Founded
- 1996
- Listed since
- Feb 17, 2005
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $359.94B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $120.63B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $104.54B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.48B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $87.30B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $74.22B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.55B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.45B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.